Liotta, L.A., Steeg, P.S., & Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell64, 327–336 (1991). ArticleCASPubMed Google Scholar
Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell86, 353–364 (1996). ArticleCASPubMed Google Scholar
Dvorak, H.F., Brown, L.F., Detmar, M. & Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol.146, 1029–1039 (1995). CASPubMedPubMed Central Google Scholar
Schulte, A.M. et al. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ line insertion of an endogenous retrovirus. Proc. Natl. Acad. Sci. USA93, 14759–14764 (1996). ArticleCASPubMedPubMed Central Google Scholar
Czubayko, F., Schulte, A.M., Berchem, G.J. & Wellstein, A. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl. Acad. Sci. USA93, 14753–14758 (1996). ArticleCASPubMedPubMed Central Google Scholar
Asano, M., Yukita, A., Matsumoto, T., Kondo, S. & Suzuki, H. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res.55, 5296–5301 (1995). CASPubMed Google Scholar
Warren, R.S., Yuan, H., Matli, M.R., Gillett, N.A. & Ferrara, N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest.95, 1789–1797 (1995). ArticleCASPubMedPubMed Central Google Scholar
Wu, D., Kan, M., Sato, G.H., Okamoto, T. & Sato, J.D. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J. Biol. Chem.266, 16778–16785 (1991). CASPubMed Google Scholar
Czubayko, F., Smith, R.V., Chung, H.C. & Wellstein, A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J. Biol. Chem, 269, 28243–28248 (1994). CASPubMed Google Scholar
Burgess, W.H. & Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem.58, 575–606 (1989). ArticleCASPubMed Google Scholar
Liaudet-Coopman, E.D.E. & Wellstein, A. Regulation of gene expression of a binding protein for fibroblast growth factor by retinoic acid. J. Biol. Chem.271, 21303–21308 (1996). ArticleCASPubMed Google Scholar
Kurtz, A., Darwiche, N., Harris, V., Wang, H.L. & Wellstein, A. Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene14, 2671–2681 (1997). ArticleCASPubMed Google Scholar
Czubayko, F., Riegel, A.T. & Wellstein, A. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth. J. Biol. Chem.269, 21358–21363 (1994). CASPubMed Google Scholar
Li, Y.S. et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science250, 1690–1694 (1990). ArticleCASPubMed Google Scholar
Fang, W.J., Hartmann, N., Chow, D., Riegel, A.T. & Wellstein, A. Pleiotrophin stimulates fibroblasts, endothelial and epithelial cells, and is expressed in human cancer. J. Biol. Chem.267, 25889–25897 (1992). CASPubMed Google Scholar
Liaudet-Coopman, E.D.E., Berchem, G.J. & Wellstein, A. In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma. Clin. Cancer Res.3, 179–184 (1997). CASPubMed Google Scholar
Horak, E.R. et al. Angiogenesis, assessed by platelet/endothelial Cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet340, 1120–1124 (1992). ArticleCASPubMed Google Scholar
Kuan, S.F., Byrd, J.C., Basbaum, C.B. & Kim, Y.S. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res.47, 5715–5724 (1987). CASPubMed Google Scholar
Chen, C.J., Banerjea, A.C., Harmison, G.G., Haglund, K. & Schubert, M. Multi-target-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication—potential effectiveness against most presently sequenced HIV-1 isolates. Nucleic Acids Res.20, 4581–4589 (1992). ArticleCASPubMedPubMed Central Google Scholar